PEAK6 Group’s MiMedx Group MDXG Stock Holding History

PEAK6 Group’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,700	Closed	-$83K	–	4925
2016 Q3	$83K	Buy	+9,700	New	+$76.8K	﹤0.01%	3678
2016 Q1	–	Sell	-18,100	Closed	-$170K	–	4783
2015 Q4	$170K	Sell	18,100 -45,800	-72%	-$397K	﹤0.01%	3557
2015 Q3	$617K	Buy	63,900 +62,700	+5,225%	+$662K	﹤0.01%	2684
2015 Q2	$14K	Buy	+1,200	New	+$12.3K	﹤0.01%	4848
2014 Q1	–	Sell	-10,000	Closed	-$87K	–	5191
2013 Q4	$87K	Buy	+10,000	New	+$61.2K	﹤0.01%	4092

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PEAK6 Group's MDXG Position: Q1 2018 in Review

PEAK6 Group sold out of MiMedx Group (MDXG) in Q1 2018, closing a stake of 77,928 shares — an estimated $983K sold.

PEAK6 Group first reported a position in MDXG in Q4 2014 and held it in 9 quarters. The position peaked at $983K in Q4 2017. 223 funds tracked by Wall St. Rank hold MDXG as of Q1 2018.

PEAK6 Group reported no remaining MiMedx Group position as of Q1 2018 after selling out during the quarter.
PEAK6 Group sold 77,928 MiMedx Group shares in Q1 2018, an estimated $983K.
PEAK6 Group first reported a position in MiMedx Group in Q4 2014 and held it in 9 quarters.
PEAK6 Group's MiMedx Group position peaked at $983K in Q4 2017.
223 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.